A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

September 29, 2023

Primary Completion Date

June 19, 2026

Study Completion Date

July 17, 2026

Conditions
Hidradenitis Suppurativa
Interventions
DRUG

SAR444656 (KT-474)

Oral Tablet

DRUG

Placebo

Oral Tablet

Trial Locations (52)

10789

Investigational Site Number : 2760005, Berlin

11009

Investigational Site Number : 7240004, Cadiz

12462

Investigational Site Number : 3000003, Athens

13496

Investigational Site Number : 4100001, Seongnam-si

15213

UPMC Montefiore- Site Number : 8400009, Pittsburgh

17011

Vial Health - DermDox Dermatology- Site Number : 8400020, Camp Hill

18014

Investigational Site Number : 7240001, Granada

33024

Encore Medical Research - 6600 Taft St- Site Number : 8400005, Hollywood

33162

Sullivan Dermatology- Site Number : 8400003, Miami

33331

Encore Medical Research - Weston- Site Number : 8400010, Weston

33436

Encore Medical Research of Boynton Beach- Site Number : 8400002, Boynton Beach

33511

Moore Clinical Research - Brandon- Site Number : 8400001, Brandon

41009

Investigational Site Number : 7240002, Seville

42897

Investigational Site Number : 2760004, Remscheid

44791

Investigational Site Number : 2760001, Bochum

46256

Dawes Fretzin Clinical Research- Site Number : 8400011, Indianapolis

46940

Investigational Site Number : 7240005, Manises

47129

Dermatology Specialists Research (DS Research) - Indiana- Site Number : 8400012, Clarksville

60590

Investigational Site Number : 2760007, Frankfurt am Main

69120

Investigational Site Number : 2760002, Heidelberg

80337

Investigational Site Number : 2760008, Munich

85255

Clear Dermatology & Aesthetics Center- Site Number : 8400006, Scottsdale

91355

Advanced Dermatology and Cosmetic Care- Site Number : 8400025, Valencia

91360

Clinical Trials Management Services - Thousand Oaks- Site Number : 8400028, Thousand Oaks

92108

Paradigm Clinical Research - San Diego - ClinEdge - PPDS- Site Number : 8400021, San Diego

92807

Cosmetic Dermatology of Orange County- Site Number : 8400024, Anaheim

97080

Investigational Site Number : 2760006, Würzburg

330721

Investigational Site Number : 4100002, Cheonan-si

4810345

Investigational Site Number : 1520004, Temuco

7580206

Investigational Site Number : 1520001, Las Condes

7640881

Investigational Site Number : 1520002, Santiago

8380000

Investigational Site Number : 1520003, Independencia

92708-3701

First OC Dermatology - Fountain Valley- Site Number : 8400007, Fountain Valley

33176-1032

ARA Professionals- Site Number : 8400023, Miami

02215-5563

Beth Israel Deaconess Medical Center - 110 Francis St- Site Number : 8400013, Boston

48124-4085

Wayne Health - Dearborn- Site Number : 8400004, Dearborn

48084-3536

Revive Research Institute-1575 W Big Beaver Rd- Site Number : 8400008, Troy

19114-1025

Clinical Research Philadelphia,LLC- Site Number : 8400026, Philadelphia

99202-1332

Dermatology Specialists of Spokane- Site Number : 8400015, Spokane

G1W 4R4

Investigational Site Number : 1240004, Québec

06847

Investigational Site Number : 2760009, Dessau

564 29

Investigational Site Number : 3000001, Pavlos Melas

546 43

Investigational Site Number : 3000002, Thessaloniki

50-449

Investigational Site Number : 6160006, Wroclaw

50-566

Investigational Site Number : 6160002, Wroclaw

90-436

Investigational Site Number : 6160005, Lodz

00-874

Investigational Site Number : 6160003, Warsaw

40-040

Investigational Site Number : 6160007, Katowice

42-624

Investigational Site Number : 6160004, Ossy

02841

Investigational Site Number : 4100003, Seongbuk-Gu

03080

Investigational Site Number : 4100004, Seoul

03010

Investigational Site Number : 7240003, Alicante

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Kymera Therapeutics, Inc.

INDUSTRY

lead

Sanofi

INDUSTRY